Recurrence of H Pylori : Incidence and Influential Factors.
ConditionH. Pylori Infection
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSohag University
About this trial
This study aims to determine recurrence rates, identify influential factors, investigate key factors that contribute to recurrence, evaluate treatment effectiveness and to assess the efficacy of different eradication regimens and their role in reducing recurrence.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: 18-75 years old.
H. pylori infection: Confirmed by endoscopy, biopsy, or non-invasive tests (e.g., urea breath test, stool antigen test).
Symptoms: Presence of dyspepsia, peptic ulcer disease, or other H. pylori-related symptoms.
Laboratory tests: Normal liver and kidney function, and no significant abnormalities in blood counts.
Disqualifiers
Patients receiving eradication therapy in the past taking proton pump inhibitors,, H2 blockers ,,bismuth ,, antibiotics or other medications that interfere with the result of the examination in the recent 4 weeks.
Gastrointestinal disorders: Severe gastrointestinal disorders (e.g., gastric cancer, inflammatory bowel disease ,gastric or duodenal ulcer with current or recent bleeding , or clinical significant gastrointestinal bleeding within 4 weeks of randomization).
Malignancies: Active or recent malignancies.
Severe comorbidities: Unstable or severe comorbidities (e.g., heart failure, liver cirrhosis).
Trial design
Design model
Single group
Treatments tested in this trial
follow up of patients that had H. Pylori infection and recieved medical treatment for recurrence
Behavioralfollow up of patients that had H. Pylori infection and recieved medical treatment for recurrence and influential factors for recurrence
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: follow up of patients that had H. Pylori infection and recieved medical treatment for recurrenceOther 1 intervention
Trial outcomes
Primary outcomes
1
recurrence of H. Pylori infection in patients who recieved medical treatment
H. Pylori antigen in stool
Time frame
4 weeks after successful medical treatmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov